ATI-1013

N/A

Report date: 2025/10/20 14:18:40

Base Information

Drug NameATI-1013
Drug Alias NameATI-1013
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-nicotine
TargetsNicotine
Therapy Area/IndicationsSmoking CessationPeripheral Vascular DiseasesThromboangiitis Obliterans
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAntidote Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSmoking CessationPeripheral Vascular DiseasesThromboangiitis Obliterans
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A